Trinity Biotech plc (TRIB) NASDAQ

0.75

-0.0448(-5.66%)

Updated at January 02 04:00PM

Currency In USD

Valuation

Market Cap79.02M
Enterprise Value174.62M
P/E Ratio-0.38
PEG Ratio-0.03
Price/Sales Ratio0.16
Price/Book Ratio-0.28
Enterprise/Revenue2.4
Enterprise/EBITDA-6.09

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.74
Operating Margin-0.44

Management Effectiveness

Return On Assets-0.37
Return On Equity0.95

Income Statement

Revenue61.56M
Revenue/Share2.66
Gross Profit21.44M
EBITDA-16.91M
Net Income-31.79M
Diluted EPS-1.77

Balance Sheet

Total Cash1.55M
Total Cash/Share0.08
Total Debt112.56M
Total Debt/Equity-2.27
Current Ratio1.05
Book Value Per Share-2.66

Price History

52-Week Change-85.37
52-Week High3.44
52-Week Low0.48
Moving Average 50 Days0.96
Moving Average 200 Days0.89

Statistics

Average Volume3.1M
Shares Outstanding10.39M
% Held by Institutions14.77

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:5
Last Split DateAugust 27, 2025